Skip to main content
TipRanks
Go Ultimate75% OFF

Eupraxia Pharmaceuticals (EPRX) Cash flow

82 Followers

Eupraxia Pharmaceuticals Cash Flow

TSE:EPRX's free cash flow for Q2 2026 was C$-12.91M. For the 2026 fiscal year, TSE:EPRX's free cash flow was decreased by C$-169.28K and operating cash flow was C$-12.74M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Mar 24Dec 22Dec 21
C$ -29.05MC$ -29.99MC$ -21.02MC$ -18.78MC$ -14.64M
C$ -599.26KC$ -75.16KC$ -73.20KC$ 8.70MC$ -14.45M
C$ 77.39MC$ 45.78MC$ 21.35MC$ 13.52MC$ 49.92M
C$ 80.42MC$ 33.10MC$ 19.30MC$ 24.74MC$ 20.89M
C$ -29.65MC$ -30.10MC$ -21.09MC$ -19.08MC$ -15.07M

Currency in CAD

Eupraxia Pharmaceuticals Cash Flow

-50M-25M025M50M75M100M201720182019202020212022202320242025OperatingInvestingFinancing